Investments (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
|
Schedule of Investments [Line Items] | ||
Amortized Cost | $ 633,623 | $ 488,544 |
Fair Value | $ 637,395 | $ 490,462 |
Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
% of Total Investments at Fair Value | 100.00% | 100.00% |
Private Debt | ||
Schedule of Investments [Line Items] | ||
Amortized Cost | $ 633,623 | $ 488,544 |
Fair Value | $ 637,395 | $ 490,462 |
Private Debt | Investment Owned, At Fair Value | Investment Type Concentration Risk | ||
Schedule of Investments [Line Items] | ||
% of Total Investments at Fair Value | 100.00% | 100.00% |
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Cost of the investment. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Fair value of investment in security owned. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|